|
|
|
Volumn 165, Issue 11, 2001, Pages 1468-1469
|
|
Give us clear, not convoluted, clinical practice guidelines [3] multiple letters
a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
TAMOXIFEN;
ANTINEOPLASTIC AGENT;
BREAST CARCINOMA;
CHEMOPROPHYLAXIS;
DECISION MAKING;
DRUG EFFICACY;
EVALUATION;
GENERAL PRACTITIONER;
LETTER;
PRACTICE GUIDELINE;
PRESCRIPTION;
PUBLICATION;
RISK ASSESSMENT;
BREAST TUMOR;
CANADA;
FEMALE;
HUMAN;
MASS SCREENING;
METHODOLOGY;
NOTE;
PATIENT SELECTION;
REPRODUCIBILITY;
STANDARD;
INTERNET;
RISK FACTOR;
ANTICARCINOGENIC AGENTS;
BREAST NEOPLASMS;
CANADA;
FEMALE;
HUMANS;
MASS SCREENING;
PATIENT SELECTION;
PRACTICE GUIDELINES;
REPRODUCIBILITY OF RESULTS;
RISK ASSESSMENT;
TAMOXIFEN;
INTERNET;
RISK FACTORS;
|
|
EID: 0035680839
PISSN: 08203946
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|